SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-026502
Filing Date
2017-05-11
Accepted
2017-05-11 16:58:26
Documents
50
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v466128_10q.htm 10-Q 301026
2 EXHIBIT 31.1 v466128_ex31-1.htm EX-31.1 13469
3 EXHIBIT 31.2 v466128_ex31-2.htm EX-31.2 13542
4 EXHIBIT 32.1 v466128_ex32-1.htm EX-32.1 6328
  Complete submission text file 0001144204-17-026502.txt   3437277

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT iliu-20170331.xml EX-101.INS 625388
6 XBRL TAXONOMY EXTENSION SCHEMA iliu-20170331.xsd EX-101.SCH 38246
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iliu-20170331_cal.xml EX-101.CAL 28214
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iliu-20170331_def.xml EX-101.DEF 281447
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE iliu-20170331_lab.xml EX-101.LAB 291141
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iliu-20170331_pre.xml EX-101.PRE 304781
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32715 | Film No.: 17835184
SIC: 2835 In Vitro & In Vivo Diagnostic Substances